Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04659213 · ClinicalTrials.gov registry record · NA
Esophagus Deviation During Radiofrequency Ablation of Atrial Fibrillation - EASY AF STUDY
A NA study of Atrial Fibrillation, sponsored by S4 Medical.
- Completed
- Registry status
- NA
- Development phase
- 129
- Enrollment target
- 1
- Study location
NCT04659213: Completed NA study of Atrial Fibrillation, sponsored by S4 Medical.
NCT04659213 is a NA study of Atrial Fibrillation that has completed, run by S4 Medical. The registered enrollment target is 129 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04659213, a NA study of Atrial Fibrillation, has completed, sponsored by S4 Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 129 participants
- Enrollment target
- 1
- Study location
Study Summary
To assess if deviating the esophagus will reduce/eliminate ablation injury to the esophagus.
Primary Outcome
The primary study endpoint is the incidence of esophageal injury attributable to RF ablation energy as noted on post ablation endoscopy
Conditions Studied
Interventions
- DEVICE esolution catheter
Study Locations (1)
Ohio
- OSU - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2022-07-31 |
| Phase | NA |
What the finished NCT04659213 record still lists
NCT04659213 is an interventional study that assigns participants to a tested intervention. The registered 129 participants enrollment target is mid-sized for trials with a published cap, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which esolution catheter is the first listed.
NCT04659213 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04659213 about?
NCT04659213 is a clinical study titled "Esophagus Deviation During Radiofrequency Ablation of Atrial Fibrillation - EASY AF STUDY". To assess if deviating the esophagus will reduce/eliminate ablation injury to the esophagus.
What is the current status of trial NCT04659213?
This trial is currently completed. It is a NA study. The enrollment target is 129 participants. The study started on 2021-09-01. Estimated completion is 2022-07-31.
What conditions does trial NCT04659213 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
What interventions are being tested in trial NCT04659213?
The interventions under investigation include: esolution catheter (DEVICE).
Who is sponsoring clinical trial NCT04659213?
This trial is sponsored by S4 Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04659213 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04659213's enrollment target sits among peer trials
129 130th of 202 higher than 73 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03619850 · 129 participants · Phase 3
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- NCT05704361 · 129 participants · Phase 1
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
- NCT05919849 · 129 participants · Phase 1
Supporting Parents in Affirming Their Children's Experiences of Stigma
- NCT06313749 · 129 participants · NA
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI